Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies

Y Yang, G Jiang, R Huang, Y Liu, X Chang… - Biochemical …, 2023 - Elsevier
Diabetic retinopathy (DR) is a common diabetic microvascular complication and the main
cause of vision loss in working-aged people. The NLRP3 inflammasome is a cytosolic …

Targeting the NLRP3 inflammasome in diabetic retinopathy: From Pathogenesis to Therapeutic Strategies.

Y Yang, G Jiang, R Huang, Y Liu… - Biochemical …, 2023 - europepmc.org
Diabetic retinopathy (DR) is a common diabetic microvascular complication and the main
cause of vision loss in working-aged people. The NLRP3 inflammasome is a cytosolic …

Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies

Y Yang, G Jiang, R Huang, Y Liu… - Biochemical …, 2023 - pubmed.ncbi.nlm.nih.gov
Diabetic retinopathy (DR) is a common diabetic microvascular complication and the main
cause of vision loss in working-aged people. The NLRP3 inflammasome is a cytosolic …

Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies

Y Yang, G Jiang, R Huang, Y Liu, X Chang, S Fu - 2023 - ir.lzu.edu.cn
摘要Diabetic retinopathy (DR) is a common diabetic microvascular complication and the
main cause of vision loss in working-aged people. The NLRP3 inflammasome is a cytosolic …